Gillian Cannon

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gillian M. Cannon.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gillian Cannon:

Company Role Class Num Shares Value Price $ Report Date Ownership
CORCEPT THERAPEUTICS INC Director Common Stock 7,393 $518,471 $70.13 04 Sep 2025 Direct
CORCEPT THERAPEUTICS INC Director Stock option (right to buy) 49,000 04 Sep 2025 Direct
Xenon Pharmaceuticals Inc. Director Share Option (Right to Buy) 17,012 05 Jun 2025 Direct
Xenon Pharmaceuticals Inc. Director Restricted Share Units 2,645 05 Jun 2025 Direct

Insider Reports Filed by Gillian Cannon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CORT CORCEPT THERAPEUTICS INC 10 Sep 2025 1 $0 4 Director 11 Sep 2025, 21:03
CORT CORCEPT THERAPEUTICS INC 04 Sep 2025 3 -$68.91 4 Director 08 Sep 2025, 20:20
CORT CORCEPT THERAPEUTICS INC 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 20:53
XENE Xenon Pharmaceuticals Inc. 05 Jun 2025 2 $0 4 Director 06 Jun 2025, 17:57
XENE Xenon Pharmaceuticals Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 17:41
CORT CORCEPT THERAPEUTICS INC 17 May 2024 1 $0 4 Director 21 May 2024, 18:25
XENE Xenon Pharmaceuticals Inc. 10 Aug 2023 1 $0 4 Director 10 Aug 2023, 18:56
XENE Xenon Pharmaceuticals Inc. 08 Aug 2023 0 $0 3 Director 10 Aug 2023, 18:40
CORT CORCEPT THERAPEUTICS INC 19 May 2023 1 $0 4 Director 23 May 2023, 17:00
CORT CORCEPT THERAPEUTICS INC 31 May 2022 1 $0 4 Director 02 Jun 2022, 17:00
CORT CORCEPT THERAPEUTICS INC 26 May 2021 1 $0 4 Director 28 May 2021, 17:05